Calcium antagonists and their potential role in the prevention of sudden coronary death.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001281:Atrial Fibrillation / Q000503:physiopathology; D001282:Atrial Flutter / Q000503:physiopathology; D001283:Atrioventricular Node / Q000378:metabolism / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D003327:Coronary Disease / Q000150:complications / Q000401:mortality* / Q000503:physiopathology; D003645:Death, Sudden / Q000209:etiology*; D004110:Diltiazem / Q000627:therapeutic use; D004285:Dogs; D000882:Haplorhini; D006801:Humans; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013610:Tachycardia / Q000378:metabolism / Q000503:physiopathology; D013779:Tetrodotoxin / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology
D002121:Calcium Channel Blockers; D007473:Ion Channels; D013779:Tetrodotoxin; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine